Video
Novartis beat its earnings forecasts Thursday, posting a 17% rise in net profit for the second quarter. Nick Turner from Mirabaud Securities...
4m 10s |
4 months ago
CNBC Video Gallery - CNBC.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Novartis
Go to Feed to see what's new!
share
keep
 
 
ThyssenKrupp beat expectations with its full-year pre-tax profit Friday. Ekkehard Schulz, CEO of ThyssenKrupp, spoke to CNBC about the outlo...
4m 56s |
4 days ago
CNBC Video Gallery - CNBC.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
ThyssenKrupp
CNBC
Go to Feed to see what's new!
share
keep
 
 
JPMorgan cuts 3,000 jobs; Dell beats expectations.
a week ago
Forbes
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Federal Home Loan Mortgage Corporation
JPMorgan Chase
Citigroup
Dell
Federal National Mortgage Association
Government sponsored enterprise
Apple Inc.
Bank of New York
Go to Feed to see what's new!
share
keep
 
 
...'s largest drugmaker's profit dropped 45 percent to $904 million, missing analyst expectations. Vasella speaks with Bloomberg's Mark Barton and Sara Walker from Basel, Switzerland. (Source: ...
10 months ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Daniel Vasella
Novartis
Vildagliptin
Chief executive officer
Go to Feed to see what's new!
share
keep
 
 
Novartis stock traded higher Monday as the pharmaceutical company exceeded market expectations after reporting a 10% jump in quarterly profi...
3m 48s |
7 months ago
CNBC Video Gallery - CNBC.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Pharmaceutical company
Novartis
Market trends
Go to Feed to see what's new!
share
keep
 
 
...Novartis ...expectations.” Sales this year alone will exceed $2.4 billion. What elements might have led to this triumph and Novartis’ more recent successes? Vasella cites “intrinsic ...
1h 3m 24s |
a year ago
MIT World
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Daniel Vasella
Imatinib
Case study
Go to Feed to see what's new!
share
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
 
 


 
Keep this video in the "Saved" list
Go to Feed to see what's new!